Basics iTeos Therapeutics, Inc. IPO Date: June 24, 2020 Sector: Healthcare Industry: Biotech Market Cap: $383.12M Activated in VL: True Average Daily Range Avg Daily Range: $0.58 | 2.81% Avg Daily Range (30 D): $0.22 | 2.79% Avg Daily Range (90 D): $0.20 | 2.81% Institutional Daily Volume Avg Daily Volume: .32M Avg Daily Volume (30 D): 1.85M Avg Daily Volume (90 D): .84M Trade Size Avg Trade Size (Sh.): 70 Avg Trade Size (Sh.) (30 D): 132 Avg Trade Size (Sh.) (90 D): 104 Institutional Trades Total Inst.Trades: 1,078 Avg Inst. Trade: $2.01M Avg Inst. Trade (30 D): $2.16M Avg Inst. Trade (90 D): $2.01M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.96M Avg Closing Trade (30 D): $1.08M Avg Closing Trade (90 D): $1.04M Avg Closing Volume: 95.14K     News Apr 29, 2025 @ 9:47 PM iTeos publie les résultats financiers de son pr... Source: N/A Apr 29, 2025 @ 9:47 PM iTeos meldet Finanzergebnisse für das erste Qua... Source: N/A Mar 7, 2025 @ 4:41 AM iTeos gibt Geschäftsergebnisse für das viert... Source: N/A Mar 7, 2025 @ 4:41 AM iTeos fait le point sur ses activités et publie... Source: N/A Jan 11, 2025 @ 1:39 PM iTeos gibt strategische Prioritäten und erwarte... Source: N/A Financials   TTM Q4 2024 FY 2024 Basic EPS $-.8 $-1.03 $-3.32 Diluted EPS $-.8 $-1.03 $-3.32 Revenue $ M $ M $ 35M Gross Profit $ $ $ Net Income / Loss $ -34.61M $ -43.71M $ -134.41M Operating Income / Loss $ -40.02M $ -49.33M $ -159.53M Cost of Revenue $ $ $ Net Cash Flow $ 13.96M $ 19.4M $ -107.09M PE Ratio